Prolonged survival in long-passage AKR leukemia using chemotherapy, radiotherapy, and adoptive immunotherapy.
D000818:Animals; D003520:Cyclophosphamide / Q000627:therapeutic use*; D005260:Female; D006087:Graft vs Host Reaction; D007116:Immunization, Passive; D007167:Immunotherapy; D007942:Leukemia, Experimental / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy; D007945:Leukemia, Lymphoid / Q000188:drug therapy / Q000401:mortality / Q000532:radiotherapy / Q000628:therapy*; D008213:Lymphocyte Activation; D051379:Mice; D008806:Mice, Inbred AKR; D008808:Mice, Inbred CBA / Q000276:immunology; D008811:Mice, Inbred DBA / Q000276:immunology; D008954:Models, Biological; D009368:Neoplasm Transplantation; D009439:Neuraminidase / Q000494:pharmacology; D013154:Spleen / Q000276:immunology; D014184:Transplantation, Homologous
D003520:Cyclophosphamide; D009439:Neuraminidase